Skip to main content

Prescription Drug Pricing: Implications for Retail Pharmacies

T-HEHS-96-216 Published: Sep 19, 1996. Publicly Released: Sep 19, 1996.
Jump To:
Skip to Highlights

Highlights

GAO discussed the implications of prescription drug pricing for retail pharmacies, focusing on the: (1) changes in the process of getting prescription drugs from manufacturers to patients; and (2) consequences for and response of retail pharmacies to these changes. GAO noted that: (1) health insurers have used their consolidated buying power to obtain drug discounts not available to retail pharmacies; (2) health insurers and pharmacy benefit managers (PBM) use the size of their member populations as leverage to help reduce the amounts that they reimburse pharmacies for prescriptions dispensed to those populations; (3) retail pharmacies have been facing increased competition from mail order pharmacies; and (4) retail pharmacies have responded to the changes in pharmaceutical pricing by waging lawsuits against leading drug manufacturers and wholesalers, developing more competitive strategies for gaining business, and campaigning for legislative action.

Full Report

Media Inquiries

Sarah Kaczmarek
Managing Director
Office of Public Affairs

Public Inquiries

Topics

CompetitionDrugsHealth care cost controlHealth insurance cost controlHealth maintenance organizationsManaged health careMedicaidPharmaceutical industryPrice adjustmentsPrices and pricingRetail facilitiesPrescription drugs